Clinical Trial Update: Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion [NA]

View source ↗

Summary

Clinical trial update describing the development of intravitreal ranibizumab to study the pathogenesis of macular edema associated with retinal vein occlusion. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Central Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Tokyo Medical University | Conditions: Macular Edema, Branch Retinal Vein Occlusion | NA | Status: UNKNOWN